跳至主要内容
临床试验/JPRN-UMIN000016347
JPRN-UMIN000016347已完成4 期

Study for the effect of blood glucose and metabolic risk factors by switching Sulfonylurea to SGLT2 inhibitor in patients with type 2 diabetes. -prospective observational study- - Switching Sulfonylurea to SGLT2 inhibitor in patients with type 2 diabetes

Hokkaido University Hospital0 个研究点目标入组 200 人开始时间: 2015年1月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Hypersensitivity to Ipragliflozine 2)Uncontrolled diabetic retinopathy 3)Severe liver dysfunction,renal dysfunction,or heart failure 4)Pregnancy,nursing woman or possibly pregnant woman 5)Severe diabetic ketosis,diabetic coma 6)Severe infection,pre and post operation,severe trauma 7)Deficiency of insulin secretion (fasting CPR <0.5 ng/ml) 8) Patients who are inadequate to enter this study due to uncontrolled diet therapy or the other reasons by physician's judgments

研究者

相似试验